Loading...
| A03413 | Pages: NA | Dec 2021 | 4702 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Wearable Injectors Market
Request Now !Wearable injectors are drug delivery devices based on single-use wearable device technologies, designed to deliver drugs in large volume to the patients treated for long duration. Rapid ongoing developments with many new designed features of these have been witnessed in the medical field. Wearable injectors offer numerous benefits to the patients due to their wide usage.
The global wearable injectors market is driven by the advantages as compared to traditional injectors, ease of customization, and increase in demand for home healthcare and advanced drug delivery system. Growth in need for subcutaneous and continuous drug delivery has created the demand for wearable injectors among the patients. However, low dosing volume of administering drugs and highly viscous nature of few drugs impede the market growth. Moreover, rise in need for better patient care and growth in focus of pharmaceutical companies to penetrate in the market offer ample opportunities for market development.
The global wearable injectors market is segmented based on type, usage, technology, mechanism of injection, therapeutic area, end user, and region. On the basis of type, it is divided into on-body {adhesive patch}, off-body {belt clip}, and hand-held. Based on usage, it is bifurcated into disposable and semi-reusable. Based on technology, it is classified into electronic injectors, mechanical injectors, and others. On the basis of mechanism of injection, it is categorized into motor-driven, spring-based, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. On the basis of therapeutic area, it is divided into diabetes, oncology, cardiovascular diseases, infectious diseases, and auto-immune disorders. Based on end user, it is divided into clinics, hospitals, ambulatory surgery centers, home care settings, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market are Enable Injections, SteadyMed Therapeutics, Inc., Insulet Corporation, UNILIFE CORPORATION, Sensile Medical AG, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Bhler Motor GmbH, Ypsomed, and Amgen Inc.,
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 WEARABLE INJECTORS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ON-BODY (ADHESIVE PATCH)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. OFF-BODY (BELT CLIP)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. HAND-HELD
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 WEARABLE INJECTORS MARKET, BY USAGE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. DISPOSABLE
5.2.1. Market size and forecast
5.3. SEMI-REUSABLE
5.3.1. Market size and forecast
CHAPTER 6 WEARABLE INJECTORS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ELECTRONIC INJECTORS
6.2.1. Market size and forecast
6.3. MECHANICAL INJECTORS
6.3.1. Market size and forecast
6.4. OTHERS
6.4.1. Market size and forecast
CHAPTER 7 WEARABLE INJECTORS MARKET, BY MECHANISM OF INJECTION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. MOTOR-DRIVEN
7.2.1. Market size and forecast
7.3. SPRING-BASED
7.3.1. Market size and forecast
7.4. EXPANDING BATTERY
7.4.1. Market size and forecast
7.5. ROTARY PUMP
7.5.1. Market size and forecast
7.6. COLLAPSIBLE RESERVOIR
7.7. PRESSURIZED GAS
7.7.1. Market size and forecast
CHAPTER 8 WEARABLE INJECTORS MARKET, BY THERAPEUTIC AREA
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. DIABETES
8.2.1. Market size and forecast
8.3. ONCOLOGY
8.3.1. Market size and forecast
8.4. CARDIOVASCULAR DISEASES
8.4.1. Market size and forecast
8.5. INFECTIOUS DISEASES
8.5.1. Market size and forecast
8.6. AUTO-IMMUNE DISORDERS
8.6.1. Market size and forecast
CHAPTER 9 WEARABLE INJECTORS MARKET, BY END USER
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. CLINICS
9.2.1. Market size and forecast
9.3. HOSPITALS
9.3.1. Market size and forecast
9.4. AMBULATORY SURGERY CENTERS
9.4.1. Market size and forecast
9.5. HOME CARE SETTINGS
9.5.1. Market size and forecast
9.6. OTHERS
9.6.1. Market size and forecast
CHAPTER 10 WEARABLE INJECTORS MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA
10.2.1. Key market trends
10.2.2. Key growth factors and opportunities
10.2.3. Market size and forecast
10.2.3.1. U.S. market size and forecast
10.2.3.2. Canada market size and forecast
10.2.3.3. Mexico market size and forecast
10.2.4. North America Wearable Injectors Market by Type
10.2.5. North America Wearable Injectors Market by Usage
10.2.6. North America Wearable Injectors Market by Technology
10.2.7. North America Wearable Injectors Market by Mechanism of Injection
10.2.8. North America Wearable Injectors Market by Therapeutic Area
10.2.9. North America Wearable Injectors Market by End User
10.3. EUROPE
10.3.1. Key market trends
10.3.2. Key growth factors and opportunities
10.3.3. Market size and forecast
10.3.3.1. Germany market size and forecast
10.3.3.2. France market size and forecast
10.3.3.3. UK market size and forecast
10.3.3.4. Spain market size and forecast
10.3.3.5. Rest of Europe market size and forecast
10.3.4. Europe Wearable Injectors Market by Type
10.3.5. Europe Wearable Injectors Market by Usage
10.3.6. Europe Wearable Injectors Market by Technology
10.3.7. Europe Wearable Injectors Market by Mechanism of Injection
10.3.8. Europe Wearable Injectors Market by Therapeutic Area
10.3.9. Europe Wearable Injectors Market by End User
10.4. ASIA-PACIFIC
10.4.1. Key market trends
10.4.2. Key growth factors and opportunities
10.4.3. Market size and forecast
10.4.3.1. Japan market size and forecast
10.4.3.2. China market size and forecast
10.4.3.3. Australia market size and forecast
10.4.3.4. India market size and forecast
10.4.3.5. Rest of Asia-Pacific market size and forecast
10.4.4. Asia-Pacific Wearable Injectors Market by Type
10.4.5. Asia-Pacific Wearable Injectors Market by Usage
10.4.6. Asia-Pacific Wearable Injectors Market by Technology
10.4.7. Asia-Pacific Wearable Injectors Market by Mechanism of Injection
10.4.8. Asia-Pacific Wearable Injectors Market by Therapeutic Area
10.4.9. Asia-Pacific Wearable Injectors Market by End User
10.5. LAMEA
10.5.1. Key market trends
10.5.2. Key growth factors and opportunities
10.5.3. Market size and forecast
10.5.3.1. Brazil market size and forecast
10.5.3.2. Turkey market size and forecast
10.5.3.3. Saudi Arabia market size and forecast
10.5.3.4. South Africa market size and forecast
10.5.3.5. Rest of LAMEA market size and forecast
10.5.4. LAMEA Wearable Injectors Market by Type
10.5.5. LAMEA Wearable Injectors Market by Usage
10.5.6. LAMEA Wearable Injectors Market by Technology
10.5.7. LAMEA Wearable Injectors Market by Mechanism of Injection
10.5.8. LAMEA Wearable Injectors Market by Therapeutic Area
10.5.9. LAMEA Wearable Injectors Market by End User
CHAPTER 11 COMPANY PROFILES
11.1. ENABLE INJECTIONS
11.1.1. Operating business segments
11.1.2. Business performance
11.1.3. Key strategic moves and developments
11.2. STEADYMED THERAPEUTICS INC.
11.2.1. Operating business segments
11.2.2. Business performance
11.2.3. Key strategic moves and developments
11.3. INSULET CORPORATION
11.3.1. Operating business segments
11.3.2. Business performance
11.3.3. Key strategic moves and developments
11.4. UNILIFE CORPORATION
11.4.1. Operating business segments
11.4.2. Business performance
11.4.3. Key strategic moves and developments
11.5. SENSILE MEDICAL AG
11.5.1. Operating business segments
11.5.2. Business performance
11.5.3. Key strategic moves and developments
11.6. WEST PHARMACEUTICAL SERVICES, INC.
11.6.1. Operating business segments
11.6.2. Business performance
11.6.3. Key strategic moves and developments
11.7. BECTON, DICKINSON AND COMPANY
11.7.1. Operating business segments
11.7.2. Business performance
11.7.3. Key strategic moves and developments
11.8. BÜHLER MOTOR GMBH
11.8.1. Operating business segments
11.8.2. Business performance
11.8.3. Key strategic moves and developments
11.9. YPSOMED
11.9.1. Operating business segments
11.9.2. Business performance
11.9.3. Key strategic moves and developments
11.10. AMGEN INC.
11.10.1 Operating business segments
11.10.2 Business performance
11.10.3 Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
